Representatives from the UK biopharmaceutical industry are calling on the government to provide more support through a specially-designated tax relief program. 13 March 2023
There will be changes impacting drugmakers doing business in Northern Ireland as a result of February’s Windsor Framework agreement between the UK and European 7 March 2023
The Irish pharmaceutical industry has urged lawmakers and regulators to resist proposals from the European Commission which it argues will “weaken intellectual 6 March 2023
The Association of the British Pharmaceutical Industry (ABPI) has attempted to show that there is a better way than the existing Voluntary Pricing and Access Sc 1 March 2023
The Secretary of the Department of Health and Human Services (HHS) has selected three new models for testing by the Centers for Medicare & Medicaid Services’ (C 15 February 2023
In the USA, the Department of Health and Human Services (HHS) has released its initial guidance for the implementation of a rebate program capping the price of 10 February 2023
As the British pharmaceutical industry gets ready to negotiate the reimbursement regime in the country, representatives have expressed dismay at a move to raise 2 February 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.